Skip to content
  • Wednesday, 18 November 2026
  • 12:27 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access
Laboratory Automation & Robotics

Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access

Lana Keisha Jun 4, 2026 0

In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…

Read More
Laboratory Automation & Robotics

Canada Becomes First G7 Nation to Approve Generic Semaglutide as Novo Nordisk Patent Lapses

Lana Keisha May 28, 2026 0

In a landmark decision poised to reshape the pharmaceutical landscape and significantly impact patient access and healthcare costs, Health Canada…

Read More
Pharmaceutical R&D

UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension

Teuku Ryan May 14, 2026 0

The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…

Read More
Laboratory Automation & Robotics

Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Novo Nordisk Patent Lapse, Paving Way for Enhanced Access and Affordability

Lana Keisha May 13, 2026 0

In a landmark decision poised to significantly reshape the pharmaceutical landscape for diabetes and obesity management, Health Canada has granted…

Read More
Science News: A Century of Empowering Public Understanding of Science5 Python Techniques for Efficient Resource OrchestrationBacteria’s Ingenious Mobility: New Research Reveals Unexpected Travel Methods Beyond FlagellaNew genetic discovery could spell this aggressive cancer’s downfall
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring SystemThe oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
YOU MAY HAVE MISSED
Neuroscience & Brain Research
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring System
Rifan Muazin Nov 5, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ